Form F-10 - Registration Statement for Securities of certain Canadian Issuers.:
SEC Accession No. 0001144204-14-044921
Filing Date
2014-07-25
Accepted
2014-07-25 14:28:53
Documents
10

Document Format Files

Seq Description Document Type Size
1 FORM F-10 v384723_f10.htm F-10 265619
2 GRAPHIC image_001.jpg GRAPHIC 4577
3 GRAPHIC image_002.jpg GRAPHIC 18050
4 GRAPHIC image_003.jpg GRAPHIC 16549
5 GRAPHIC image_002.gif GRAPHIC 108
6 GRAPHIC image_003.gif GRAPHIC 78
7 GRAPHIC image_004.gif GRAPHIC 76
8 GRAPHIC image_005.gif GRAPHIC 6579
9 EXHIBIT 5.1 v384723_ex5-1.htm EX-5.1 3685
10 EXHIBIT 5.2 v384723_ex5-2.htm EX-5.2 3471
  Complete submission text file 0001144204-14-044921.txt   338142
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: F-10 | Act: 33 | File No.: 333-197633 | Film No.: 14993921
SIC: 2834 Pharmaceutical Preparations